Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 30, 2016 | $30.9B |
| FY2017, ended Oct 29, 2017 | $59.9B |
| FY2018, ended Oct 28, 2018 | $31.0B |
| FY2019, ended Oct 27, 2019 | $51.0B |
| FY2020, ended Oct 25, 2020 | $55.7B |
| FY2021, ended Oct 31, 2021 | $121B |
| FY2022, ended Oct 30, 2022 | $75.7B |
| FY2023, ended Oct 29, 2023 | $109B |
| FY2024, ended Oct 27, 2024 | $152B |
| FY2025, ended Oct 26, 2025 | $181B |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $426B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 30, 2016 | $10.8B |
| FY2017, ended Oct 29, 2017 | $14.7B |
| FY2018, ended Oct 28, 2018 | $16.7B |
| FY2019, ended Oct 27, 2019 | $14.6B |
| FY2020, ended Oct 25, 2020 | $17.2B |
| FY2021, ended Oct 31, 2021 | $23.1B |
| FY2022, ended Oct 30, 2022 | $25.8B |
| FY2023, ended Oct 29, 2023 | $26.5B |
| FY2024, ended Oct 27, 2024 | $27.2B |
| FY2025, ended Oct 26, 2025 | $28.4B |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $30.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 30, 2016 | $1.72B | $2.31B |
| FY2017, ended Oct 29, 2017 | $3.52B | $3.44B |
| FY2018, ended Oct 28, 2018 | $3.04B | $3.17B |
| FY2019, ended Oct 27, 2019 | $2.71B | $2.81B |
| FY2020, ended Oct 25, 2020 | $3.62B | $3.38B |
| FY2021, ended Oct 31, 2021 | $5.89B | $4.77B |
| FY2022, ended Oct 30, 2022 | $6.53B | $4.61B |
| FY2023, ended Oct 29, 2023 | $6.86B | $7.59B |
| FY2024, ended Oct 27, 2024 | $7.18B | $7.49B |
| FY2025, ended Oct 26, 2025 | $7.00B | $5.70B |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $9.27B | $5.62B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 30, 2016 | $3.41B |
| FY2017, ended Oct 29, 2017 | $5.01B |
| FY2018, ended Oct 28, 2018 | $3.44B |
| FY2019, ended Oct 27, 2019 | $3.13B |
| FY2020, ended Oct 25, 2020 | $5.35B |
| FY2021, ended Oct 31, 2021 | $5.00B |
| FY2022, ended Oct 30, 2022 | $2.00B |
| FY2023, ended Oct 29, 2023 | $6.13B |
| FY2024, ended Oct 27, 2024 | $8.02B |
| FY2025, ended Oct 26, 2025 | $7.24B |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $7.04B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 30, 2016 | $3.33B |
| FY2017, ended Oct 29, 2017 | $5.30B |
| FY2018, ended Oct 28, 2018 | $5.31B |
| FY2019, ended Oct 27, 2019 | $5.91B |
| FY2020, ended Oct 25, 2020 | $5.45B |
| FY2021, ended Oct 31, 2021 | $5.45B |
| FY2022, ended Oct 30, 2022 | $5.46B |
| FY2023, ended Oct 29, 2023 | $5.56B |
| FY2024, ended Oct 27, 2024 | $6.96B |
| FY2025, ended Oct 26, 2025 | $6.55B |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $7.74B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 26.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 30, 2016 | 1.08B |
| FY2017, ended Oct 29, 2017 | 1.06B |
| FY2018, ended Oct 28, 2018 | 959M |
| FY2019, ended Oct 27, 2019 | 915M |
| FY2020, ended Oct 25, 2020 | 914M |
| FY2021, ended Oct 31, 2021 | 889M |
| FY2022, ended Oct 30, 2022 | 844M |
| FY2023, ended Oct 29, 2023 | 831M |
| FY2024, ended Oct 27, 2024 | 814M |
| FY2025, ended Oct 26, 2025 | 793M |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | 794M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Oct 30, 2016 | $1.89B | $201M | $88.0M |
| FY2017, ended Oct 29, 2017 | $1.17B | $220M | $97.0M |
| FY2018, ended Oct 28, 2018 | $5.28B | $258M | $124M |
| FY2019, ended Oct 27, 2019 | $2.40B | $263M | $145M |
| FY2020, ended Oct 25, 2020 | $649M | $307M | $174M |
| FY2021, ended Oct 31, 2021 | $3.75B | $346M | $175M |
| FY2022, ended Oct 30, 2022 | $6.10B | $413M | $199M |
| FY2023, ended Oct 29, 2023 | $2.19B | $490M | $227M |
| FY2024, ended Oct 27, 2024 | $3.82B | $577M | $243M |
| FY2025, ended Oct 26, 2025 | $4.89B | $668M | $261M |
| Trailing 12 months to Jul 26, 2026 (through Q3 FY2026) | $2.03B | $701M | $263M |
Valuation
At current price- Market Cap
- $314B
- P/E
- 33.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 10.2×
- Price / Book
- 12.3×
- EV / EBITDA
- 32.6×
Growth
Trailing 12 months- Revenue (TTM)
- $30.8B
- Revenue Growth YoY
- 7.8%
- Revenue CAGR 3Y
- 3.2%
- Revenue CAGR 5Y
- 10.5%
- EPS Growth YoY
- 38.3%
- Net Income Growth YoY
- 35.6%
Profitability
Trailing 12 months- Gross Margin
- 49.4%
- Operating Margin
- 29.6%
- Net Margin
- 30.1%
- FCF Margin
- 18.2%
- Return on Equity
- 41.1%
Earnings
Trailing 12 months- Net Income
- $9.27B
- EPS (diluted)
- $11.59
- EBITDA
- $9.67B
- Operating Income
- $9.14B
Balance Sheet
As of Jul 26, 2026- Cash and cash equivalents
- $7.04B
- Total Debt
- $7.74B
- Net Debt
- $706M
- Total Assets
- $43.5B
- Total Liabilities
- $17.9B
- Shareholders' Equity
- $25.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.40B
- Capital Expenditure
- $2.77B
- Free Cash Flow
- $5.62B
Dividends and risk
Last 12 months- Dividend Yield
- 0.5%
- Dividend / Share
- $1.98
- Beta (5Y)
- 1.58
Every ratio is calculated from the company’s reported figures.